Find a Publication
Search Results - The search found 1169 results
Year: 2016
Journal article
Copeland, J., & Alperstein, D. (2016). Cannabis: use, harms, disorder, and interventions. Australian Clinical Psychologist, 2(1), 20103. Retrieved from http://www.acpa.org.au/.
Year: 2016
Journal article
Copeland, J., & Pokorski, I. (2016). Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review. Substance Abuse and Rehabilitation, 7, 41-53. doi: 10.2147/SAR.S89857
Year: 2016
Journal article
Copeland, J., Gates, P., & Pokorski, I. (2016). A narrative review of psychological cannabis use treatments with and without pharmaceutical adjunct. Current Pharmaceutical Design, 22, 1-12. doi: 10.2174/1381612822666160831094811.
Year: 2016
Journal article
Courtney, R. J., Clare, P., Boland, V., Matire, K. A., Bonevski, B., Hall, W., Siahpush, M., Borland, R., Doran, C. M., West, R., Farrrell, M., & Mattick, R. P. (2017). Predictors of retention in a randomised trial of smoking cessation in low-socioeconomic status Australian smokers. Addictive Behaviors, 64, 13-20. doi: 10.1016/j.addbeh.2016.07.019
Year: 2016
Book chapter
Crome, E., Baillie, A., Teesson, M., Kay-Lambkin, F., & Deady, M. (2016). Implementation of evidence-based interventions: Barriers and opportunities. In R. G. Menzies, M. Kyrios & N. Kazantzis (Eds.), Innovations and future directions in the behavioural and cognitive therapies (pp. 277-281). Samford Valley, Qld: Australian Academic Press.
Year: 2016
Journal article
Currier, D., Pirkis, J., Carlin, J., Degenhardt, L., Dharmage, S. C., Giles-Corti, B., Gordon, I., Gurrin, L., Hocking, J., Kavanagh, A., Keogh, L. A., Koelmeyer, R., LaMontagne, A. D., Schlichthorst, M., Patton, G., Sanci, L., Spittal, M. J., Studdert, D. M., Williams, J., & English, D. R. (2016). The Australian longitudinal study on male health-methods. BMC Public Health, 16 (Supplement 3), 3698. doi: 10.1186/s12889-016-3698-1
Year: 2016
Journal article
Cysique, L. A., Dermody, N., Carr, A., Brew, B. J., & Teesson, M. (2016). The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults. Journal of Neurovirology, 22(1), 56-65. doi: 10.1007/s13365-015-0368-5
Year: 2016
Journal article
Darke, S. (2016). Addiction classics: Editorial note. Addiction, 111(11), 1899. doi: 10.1111/add.13516
Year: 2016
Journal article
Darke, S. (2016). Heroin overdose: Addiction classics. Addiction, 111(11), 2060-2063. doi: 10.1111/add.13516
Year: 2016
Journal article
Darke, S. (2016). Psychosocial interventions for mental and substance use disorders: a framework for establishing evidence-based standards MARY JANE ENGLAND, ADRIENNE STITH BUTLER & MONICA L. GONZALEZ (EDITORS); COMMITTEE ON DEVELOPING EVIDENCE-BASED STANDARDS FOR PSYCHOSOCIAL INTERVENTIONS FOR MENTAL DISORDERS Washington, DC, USA: National Academies Press, 2015 ISBN: 978-0-309-31694-1, 176 pp. Paperback. Price: US$48.00 (or available free online): critique. Drug and Alcohol Review, 35(4), 503. doi: 10.1111/dar.12373
Year: 2016
Journal article
Darke, S., & Duflou, J. (2016). Response to Ruan and colleagues concerning ‘The toxicology of heroin-related death: estimating survival times’: letter to the editor. Addiction, 111(12), 2262. doi: 10.1111/add.13587
Year: 2016
Journal article
Darke, S., & Duflou, J. (2016). The toxicology of heroin-related death: estimating survival times. Addiction, 111, 1607-1613. doi:10.1111/add.13429
Year: 2016
Journal article
Darke, S., & Farrell, M. (2016). Commentary on Singh et al "Topiramate for cocaine dependence: a systematic review and meta-analysis of randomized control trials". Still searching for the answer. Addiction, 111(8), 1347. doi: 10.1111/add.13369
Year: 2016
Journal article
Darke, S., & Farrell, M. (2016). Response to commentaries on ‘Which medications are suitable for agonist drug maintenance’. Addiction, 111(5), 781-782. doi: 10.1111/add.13359
Year: 2016
Journal article
Darke, S., & Farrell, M. (2016). The twenty-first century opioid epidemic: what is happening and what can be done? The Addictions Newsletter, Spring, 18-20. Retrieved from http://www.apa.org/divisions/div50/Newsletters/tan-spring-2016.pdf.
Year: 2016
Journal article
Darke, S., & Farrell, M. (2016). Which medications are suitable for agonist drug maintenance? Addiction, 111(5), 767-774. doi: 10.1111/add.13158
Year: 2016
Journal article
Darke, S., Marel, C., Mills, K. L., Ross, J., Slade, T., & Teesson, M. (2016). Years of potential life lost amongst heroin users in the Australian Treatment Outcome Study cohort, 2001-2015. Drug and Alcohol Dependence, 162, 206-210. doi: 10.1016/j.drugalcdep.2016.03.010
Year: 2016
Journal article
Darke, S., Slade, T., Ross, J., Marel, C., Mills, K. L., & Teesson, M. (2016). Patterns and correlates of injecting among heroin users: A 11-year follow-up of the Australian Treatment Outcome Study cohort. Addictive Disorders and Their Treatment, 15(3), 111-119. doi: 10.1097/ADT.0000000000000082
Year: 2016
Journal article
Davies, S. J. C., Pearson, R. M., Stapinski, L., Bould, H., Christmas, D. M., Button, K. S., Skapinakis, P., Lewis, G., & Evans, J. (2016). Symptoms of generalized anxiety disorder but not panic disorder at age 15 years increase the risk of depression at 18 years in the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort study. Psychological Medicine, 46(1), 73-85. doi: 10.1017/S003329171500149X
Year: 2016
Journal article
Day, C. A., Shanahan, M., Wand, H., Topp, L., Haber, P. S., Rodgers, C., Deacon, R., Walsh, N., Kaldor, J., van Beek, I., Maher, L., & Hepatitis Acceptability Group Vaccine Incentives Trial Study, G. (2016). Development of immunity following financial incentives for hepatitis B vaccination among people who inject drugs: A randomized controlled trial. Journal of Clinical Virology, 74, 66-72. doi: 10.1016/j.jcv.2015.11.031
Year: 2016
Journal article
Deacon, R. M., Nielsen, S., Leung, S., Rivas, G., Cubitt, T., Monds, L. A., Ezard, N., Larance, B., & Lintzeris, N. (2016). Alprazolam use and related harm among opioid substitution treatment clients – 12 months follow up after regulatory rescheduling. International Journal of Drug Policy, 36, 104-111. doi: 10.1016/j.drugpo.2016.06.006
Year: 2016
Journal article
Deady, M., Mills, K. L., Teesson, M., & Kay-Lambkin, F. (2016). An online intervention for co-occurring depression and problematic alcohol use in young people: primary outcomes from a randomized controlled trial. Journal of Medical Internet Research, 18(3), e71. doi: 10.2196/jmir.5178
Year: 2016
Book chapter
Deady, M., Mills, K., Teesson, M., Kay-Lambin, F., Ross, J., Baillie, A., & Subotic, M. (2016). How do we best treat comorbid substance use and mental disorders? Evidence-based approaches to integrated treatment. In R. G. Menzies, M. Kyrios & N. Kazantzis (Eds.), Innovations and future directions in the behavioural and cognitive therapies (pp. 207-211). Samford Valley, Qld: Australian Academic Press.
Year: 2016
Book chapter
Degenhardt, L., & Hall, W. D. (2016). The impact of illicit drugs on public health. In H. H. Brownstein (Ed.), The Handbook of Drugs and Society (pp. 300-319). Hoboken, N.J.: John Wiley & Sons.
Year: 2016
Journal article
Degenhardt, L., Charlson, F., Stanaway, J., Larney, S., Alexander, L. T., Hickman, M., Cowie, B., Hall, W. D., Strang, J., Whiteford, H., & Vos, T. (2016). Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013. The Lancet Infectious Diseases, 16(12), 1385-1398. doi: 10.1016/S1473-3099(16)30325-5